In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus
April 28th, 2023
890 views
The present protocol describes a method to deliver drugs and gene expression-modifying agents perivascularly in an in utero developing fetus. Importantly, the effect of drugs/agents on blood flow can be measured with the progression of pregnancy.
Overview
This protocol outlines a method for perivascular delivery of drugs and gene expression-modifying agents to an in utero developing fetus. It allows for the measurement of the effects of these agents on blood flow throughout pregnancy.
Key Study Components
Area of Science
- Neuroscience
- Developmental Biology
- Pharmacology
Background
- Traditional methods for assessing chemical effects on arterial contractility include ex vivo wire myography.
- This technique allows for in vivo examination of drug effects on arterial segments.
- Chronic exposure and long-term evaluation of drug effects are possible with this method.
- Isolated vessels in organ baths do not allow for such evaluations.
Purpose of Study
- To develop a method for drug delivery to the fetal environment.
- To assess the impact of drugs on fetal blood flow.
- To enhance understanding of vascular responses during fetal development.
Methods Used
- Perivascular drug delivery technique.
- In utero exposure of the fetus to agents.
- Measurement of blood flow effects during pregnancy progression.
- Standard laparotomy incision for fetal exteriorization.
Main Results
- Demonstrated feasibility of perivascular drug delivery in fetuses.
- Established a method for monitoring blood flow changes.
- Provided insights into the effects of drugs on arterial contractility.
- Highlighted advantages over traditional organ bath methods.
Conclusions
- The protocol enables effective drug delivery and monitoring in developing fetuses.
- It offers a novel approach to studying vascular responses in vivo.
- Future studies can build on this method to explore various therapeutic agents.
Frequently Asked Questions
What is the main advantage of this technique?
The main advantage is the ability to conduct chronic exposure and long-term evaluations of drug effects on arterial contractility and blood flow.
How is the fetus exteriorized for the procedure?
A standard laparotomy incision is performed over the linear alba to begin exteriorizing the fetus.
What types of agents can be delivered using this method?
Both drugs and gene expression-modifying agents can be delivered perivascularly.
Can the effects of the agents be measured?
Yes, the effects on blood flow can be measured as pregnancy progresses.
What prior methods were used to examine chemical effects on arterial contractility?
Previously, ex vivo wire myography in organ baths was the chief method used.
What is the significance of this new technique?
It allows for in vivo examination of drug effects, which is not possible with isolated vessels in organ baths.
Executive Industry Relevance
Real-time in vivo measurement of drug effects on carotid blood flow in the ovine fetus enables direct assessment of vascular contractility and autoregulation during development. This approach addresses a critical gap in translational vascular biology by allowing chronic, localized pharmacological and genetic manipulation in a physiologically relevant fetal environment. The method supports predictive confidence for target validation and mechanistic de-risking in early-stage cardiovascular and neurovascular drug discovery.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of vascular targets and pathways in a living fetal system.
- Supports mechanistic de-risking by distinguishing local versus systemic drug effects on blood flow.
- Facilitates functional validation of adrenergic and gene-modifying interventions in cerebrovascular regulation.
- Provides predictive data for prioritizing targets implicated in developmental vascular disorders.
Screening & Assay Development
- Establishes a validated in vivo platform for quantitative measurement of arterial contractility and blood flow.
- Supports assay reproducibility and standardization for chronic drug exposure studies.
- Enables screening of compounds or vectors for localized vascular effects in a developmental context.
- Prepares biological systems for downstream translational and preclinical workflows.
Translational & Preclinical Research
- Aligns with disease-relevant models of impaired cerebral autoregulation in preterm neonates.
- Enables continuity from discovery through preclinical validation of vascular interventions.
- Supports risk-adjusted advancement of candidates targeting fetal or neonatal cerebrovascular health.
- Provides a platform for evaluating translational biomarkers of vascular function.
Pipeline & Workflow Integration
This method bridges early discovery and preclinical research by enabling hypothesis testing, target validation, and quantitative assessment of vascular function in vivo. It is positioned for use from target identification through lead optimization in cardiovascular and neurovascular pipelines.
- Discovery Biology: Supports hypothesis-driven testing of vascular targets and pathways in a physiologically relevant fetal model.
- Screening: Delivers reproducible, quantitative blood flow and contractility readouts for compound evaluation.
- Analytics: Provides real-time measurement of dependent variables such as carotid blood flow and systemic blood pressure.
- Translational Research: Enables alignment with disease-relevant endpoints and biomarker strategies for preterm cerebrovascular risk.
- Enterprise Reuse: Offers a reusable in vivo platform adaptable to other vessels, agents, and developmental stages.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in vascular target validation.
- Operational Value: Standardizes chronic in vivo assessment of drug and gene effects on blood flow.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling early de-risking of vascular interventions.
- Portfolio Impact: Supports risk-adjusted prioritization of candidates for developmental and neonatal vascular indications.
Implementation Considerations
- Requires expertise in fetal surgery, vascular instrumentation, and in vivo pharmacology.
- Demands specialized instrumentation for real-time blood flow and pressure measurement.
- Necessitates rigorous cross-team standardization for reproducibility and data integrity.
- Adaptable to various vessel types and developmental stages with appropriate protocol modifications.
- Careful surgical technique is essential to avoid vessel damage and ensure reliable data.
Biopharma FAQs
Why does null hypothesis testing matter for carotid blood flow studies?
Null hypothesis testing enables objective evaluation of whether drug or gene interventions produce statistically significant changes in carotid blood flow, supporting robust target validation and reducing false positives in early discovery.
How does independent variable isolation fit the perivascular drug delivery workflow?
By delivering agents directly to the carotid artery segment, the protocol isolates local vascular effects from systemic influences, clarifying mechanistic pathways and enhancing predictive confidence for target engagement.
What do quantitative dependent variable measurements enable in this protocol?
Real-time measurement of carotid blood flow and systemic blood pressure provides quantitative endpoints for comparing intervention effects, supporting data-driven advancement and cross-study comparability.
Why are replication requirements critical for cross-functional collaboration in fetal vascular studies?
Replication ensures that observed drug or gene effects on blood flow are reproducible across experiments and teams, facilitating reliable data sharing and integrated decision-making in multi-disciplinary R&D environments.
What statistical analysis capabilities are required before implementing in vivo carotid flow studies?
Teams must be equipped to perform statistical comparisons of blood flow and pressure data, assess significance thresholds, and interpret variability to support rigorous go/no-go decisions in the discovery pipeline.
